These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Cardiac arrest and vinorelbine? Apropos of a case and review of the literature]. Vincent L; Lamrini R; Pommier P; Martel I; Helfre S; Carrie C Rev Pneumol Clin; 1997; 53(6):360-1. PubMed ID: 9616834 [TBL] [Abstract][Full Text] [Related]
10. Oral vinorelbine may not induce acute pain at the tumor site. Tralongo P; Di Mari A; Agueli R; Gebbia V J Pain Symptom Manage; 2006 Sep; 32(3):197-9. PubMed ID: 16939839 [No Abstract] [Full Text] [Related]
11. Morphine in the treatment of incident pain triggered by vinorelbine infusion. Porzio G; Aielli F; Verna L; Ciccone S; Santomaggio A; Cannita K; Ficorella C J Pain Symptom Manage; 2008 Mar; 35(3):238-9. PubMed ID: 18215494 [No Abstract] [Full Text] [Related]
12. Myocardial ischemia and infarction associated with vinorelbine. Bergeron A; Raffy O; Vannetzel JM J Clin Oncol; 1995 Feb; 13(2):531-2. PubMed ID: 7844615 [No Abstract] [Full Text] [Related]
13. [Respiratory complications of the vinorelbine-mitomycin combination]. Rouzaud P; Estivals M; Pujazon MC; Carles P; Lauque D Rev Mal Respir; 1999 Feb; 16(1):81-4. PubMed ID: 10091264 [TBL] [Abstract][Full Text] [Related]
14. [Acute dyspnea following intravenous administration of vinblastine/mitomycin C]. Lagler U; Gattiker HH Schweiz Med Wochenschr; 1989 Mar; 119(9):290-2. PubMed ID: 2496465 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity. Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Saijo N; Nishiwaki Y Lung Cancer; 2007 Mar; 55(3):337-41. PubMed ID: 17126951 [TBL] [Abstract][Full Text] [Related]
16. Vinorelbine-induced pancreatitis: a case report. Tester W; Forbes W; Leighton J J Natl Cancer Inst; 1997 Nov; 89(21):1631. PubMed ID: 9362167 [No Abstract] [Full Text] [Related]
17. A phase I study of a daily x3 schedule of intravenous vinorelbine for refractory epithelial ovarian cancer. Gershenson DM; Burke TW; Morris M; Bast RC; Guaspari A; Hohneker J; Wharton JT Gynecol Oncol; 1998 Sep; 70(3):404-9. PubMed ID: 9790795 [TBL] [Abstract][Full Text] [Related]
19. Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate. Mackler NJ; Dunn RL; Hellerstedt B; Cooney KA; Fardig J; Olson K; Pienta KJ; Smith DC Cancer; 2006 Jun; 106(12):2617-23. PubMed ID: 16691618 [TBL] [Abstract][Full Text] [Related]
20. Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer. Briasoulis E; Pappas P; Puozzo C; Tolis C; Fountzilas G; Dafni U; Marselos M; Pavlidis N Clin Cancer Res; 2009 Oct; 15(20):6454-61. PubMed ID: 19808873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]